Skip to content

Evaluation of different knee cooling devices to control pain after knee replacement surgery

ALASKA trial, A single-centre, two-arm, controlled, prospective randomized trial comparing AIRCAST® KNEE CRYO/CUFF™ passive compressive cryotherapy with VPULSE® active compressive cryotherapy after knee arthroplasty surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17454353
Enrollment
88
Registered
2024-05-08
Start date
2023-02-01
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post surgical pain management in knee replacement for osteoarthritis Musculoskeletal Diseases

Interventions

Control (standard care) arm - AIRCAST® KNEE CRYO/CUFF™ Once the operation is finished, a wound dressing is applied and a standard bandage is applied. It consists of one layer of soft synthetic bandage

Sponsors

North Cumbria Integrated Care NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 110 Years

Inclusion criteria

Inclusion criteria: 1. Patient who is listed for knee arthroplasty (replacement) surgery, either partial or total knee replacement (unilateral). 2. Clinical indication, in the opinion of the treating surgeon, that compression & cooling therapy may be of benefit to the patient 3. Adult patients aged > 18 years 4. Mental capacity to give written informed consent

Exclusion criteria

Exclusion criteria: 1. Under the age of 18 years 2. Unable to fully understand the consent process and provide informed consent due to either language barriers or mental capacity 3. Revision of previous knee replacement or osteotomy on the index leg. 4. Limited life expectancy, i.e. undergoing palliative care 5. Any condition that is associated with excessive bleeding, coagulation abnormalities or any other significant haematological condition (e.g. Factor V Leiden, haemophilia). 6. Cardiovascular or vascular condition that in the opinion of the treating surgeon contraindicates the use of compression bandaging, including moderate to severe peripheral arterial disease, venous leg ulcer, high dose anti-coagulant medication 7. Any skin or other condition that contraindicates the use of compression and cooling therapy. 8. Patients who are participating in another interventional research study involving an investigational product related to the knee procedure and its aftercare. 9. The patient has concurrent (medical) conditions that in the opinion of the investigator may compromise patient safety or study objectives. 10. Patient has practical or mobility issues which will prevent them from removing the device themselves

Design outcomes

Primary

MeasureTime frame
1. Pain at rest is measured using the visual display scale (VDS) at baseline at pre-surgery, and 1, 3, 5,12 days and 6 weeks post-surgery 2. Pain (walking) is measured using the visual display scale (VDS) at baseline at pre-surgery, and 1, 3, 5,12 days and 6 weeks post-surgery 3. Types of pain are measured using the McGill pain questionnaire at baseline at pre-surgery, and 1, 3, 5,12 days and 6 weeks post-surgery 4. Knee limb range of motion is measured with a goniometer at baseline at pre-surgery, and 6 weeks post-surgery 5. Knee functionality is measured with validated KOOS score at baseline at pre-surgery, and 6, 12 weeks post-surgery 6. Patient satisfaction with the allocated cooling therapy is measured at 5 days post-surgery

Secondary

MeasureTime frame
There are no secondary outcome measures

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Aug 25, 2026